Rheumatoid Arthritis

Botulism toxins, already used to treat some nerve disorders as well as wrinkles in the form of Botox, can be re-engineered to potentially treat inflammatory diseases such as rheumatoid arthritis, asthma, and psoriasis, a new study finds.

Horizon Pharma announced last Tuesday that the FDA had accepted its new drug application for Lodotra, a delayed-release formulation of low-dose prednisone, for treatment of rheumatoid arthritis in adults.

Complementary and alternative medicine is highly prevalent among African Americans with rheumatoid arthritis, a new study finds.

In this video, Dr. Neil Riordan, Founder and President of the Stem Cell Institute in Panama, discusses the scientific rationale for using adipose tissue-derived stem cells and T-regulatory cells to treat MS and rheumatoid arthritis.

Tumor necrosis factor-α antagonists used to treat autoimmune diseases such as rheumatoid arthritis may pose less risk of serious infection than previously thought, a new study suggests.

With more patients and practitioners expressing interest in non-Western modes of healing and other complementary and alternative forms of medicine, researchers are studying whether traditional Chinese methods like tai chi are effective in treating arthritis and other painful conditions.

Women under 50 with rheumatoid arthritis have an increased risk of breaking bones compared with women who do not have the condition, a new study finds.

A study using MRI to monitor rheumatoid arthritis progression found that golimumab plus methotrexate produced better results than methotrexate alone.

This is a day meant to raise awareness of individuals suffering from rheumatic and musculoskeletal diseases (RMDs) as well as to give such sufferers support and an opportunity to voice their opinions, hopes, and frustrations.

Horizon Pharma has submitted a new drug application to the FDA for LODOTRA, a delayed-release formulation of low-dose prednisone to treat rheumatoid arthritis.

Novartis has announced positive results in the first Phase III trial of ACZ885 (canakinumab) for patients with systematic juvenile idiopathic arthritis.

Tumor necrosis factor inhibitors used to treat rheumatoid arthritis have been linked to increased risk of skin cancer.

Vertex Pharmaceuticals, Inc. has announced positive results of a Phase 2a trial of its investigational JAK3 inhibitor VX-509 for rheumatoid arthritis.

In a Cleveland Clinic video, William Rigby, MD, of Dartmouth Medical School, discusses B-cell and T-cell-directed therapy for rheumatoid arthritis.

Confidence in Physical Ability Helps Rheumatoid Arthritis Patients Cope with Less Pain & Attain Physical Goals

Arthritis patients taking methotrexate have a reduced antibody response compared with those taking other treatments, a study finds.

Roy Fleischmann, MD, discusses clinical aspects, outcomes, and measures regarding rheumatoid arthritis.

Research on mice has found evidence of a genetic cause of rheumatoid arthritis and could open the door to development of a new line of drugs.

Those suffering from rheumatoid arthritis are at increased risk of dying from cardiovascular disease, a new study finds.

AB Science has recruited its first patient in a phase 2b/3 study of its orally administered drug masitinib as a treatment for rheumatoid arthritis.

Antares Pharma, Inc. has announced positive results of an auto-injector that delivers a rapid subcutaneous injection of methotrexate.

Chef Seamus Mullen has found relief from rheumatoid arthritis through medication-and a diet that emphasizes fresh ingredients from Spanish cuisine.

Researchers in China report finding evidence of genetic links to rheumatoid arthritis and the related condition ankylosing spondylitis.

A video discussion of the pathology, clinical characteristics, and diagnosis of rheumatoid arthritis.

The FDA declined to approve Simponi (golimumab) for use in limiting the advance of structural damage in patients with moderate to severe rheumatoid arthritis.

Researchers hope a device that stimulates the vagus nerve will reduce pain and swelling as well as joint damage in rheumatoid arthritis patients.

An observational study finds evidence for the benefits of starting drug treatment within three months of rheumatoid arthritis diagnosis.

Regeneron and Sanofi have announced promising results of a mid-stage clinical trial of their drug sarilumab as a treatment for rheumatoid arthritis.

Scaling Mt. Everest is a tremendous achievement even for the fittest of climbers. For those suffering from rheumatoid arthritis, it was unheard of-until now.

Recent studies have shown that TNF inhibitors and hydroxychloroquine may also reduce the risk of diabetes in people.